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Tumor Staging and PFT Placement
No PFT PFT
LVHN patient 
database searched for 
patients diagnosed 
with head and/or 
neck cancer between 
the years 2016-2019.
Weight loss in pounds 
and percentages at 
various intervals 





Other relevant patient 
characteristics, such 
as gender, age, 
ethnicity, nodal 
involvement, and 
tumor location were 





comparing those that 
did not receive a PFT 
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Level of Nodal Involvement
Nodal Involvement and PFT Placement 
No PFT PFT placed
This retrospective chart review will seek to identify baseline 
characteristics of patients who will likely benefit from having a feeding 
tube (FT) placed prophylactically rather than reactively. Factors such 
as age, baseline BMI, pretreatment weight loss, ECOG score, tumor 
location, presence of dysphagia, nodal (N) status, tumor (T) status, 
and chemotherapy regimen will be evaluated. Patient outcomes, such 
as treatment completion, breaks in treatment, hospital admissions, 
weight loss, and FT usage at the end of treatment will be evaluated to 
determine if FT placement resulted in improved patient outcomes. 
• The final sample size is n=62. No results of this study reached 
statistical significance because of the small sample size. 
• Of the 62 patients that were included in the study, 71%(44) had a 
PFT placed. Of the patients that did not receive a PFT, 17%(3) had a 
FT placed reactively. 
• Demographics: The results of this study indicate that the incidence 
of HNC is disproportionately high in those of the male 
gender(83.9%), in past and current smokers (79%) and in 
White/Caucasian patients (91.9%). 
• There is currently no standard protocol for clinicians to follow when 
deciding whether or not to place a prophylactic feeding tube (PFT) 
in patients with head and neck cancer (HNC).
• Because of the risks involved in having a PFT placed, such as 
reduced swallowing function, clinicians need a definite guideline to 




































not a PFT was 
placed
HPV status of 
the tumor did 
not predict 
whether or 
not a PFT was 
placed.
81.3% of patients 
that received 
weekly Cisplatin 
had a PFT placed 
compared to only 
52% of patients 
that received 









Those that did 
have a PFT placed 
experienced less 
weight loss (by an 
average of 6.1 lbs. 
than those that 
did not receive a 
PFT.
The results of this preliminary study indicate that a lower initial BMI, a 
higher tumor status, experiencing pretreatment dysphagia, and type 
of chemotherapy used are baseline characteristics used to determine 
placement of a PFT. However, given the small sample size of this study, 
further research may find that the other factors mentioned in the 
study, such as nodal involvement and age, are also linked to the 
placement of a PFT. This study also looked at how having a PFT placed 
impacts treatment and patient outcomes. While it did not find that 
having a PFT placed had a significant impact on treatment completion, 
it did reduce weight loss during treatment, which indicates improved 
nutritional status. Also, it does not appear that the majority of 
patients used their FT for longer than the 3-4 month follow up. This 
study will be continued with a larger sample size in order to yield 
statistically significant results. One aspect that is in much of the 
literature that was not captured in our study is to what extent the 
patient uses the FT to meet their nutritional needs. This would be 
interesting data to capture in the future. 
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This study had several limitations that reduces the generalizability and 
scope. 1) The small sample size of this study made it difficult to obtain 
statistically significant results. 2) Generalizability of this study is small 
because it is a single center study that reviewed a population of 
limited diversity. 3) While the strict inclusion criteria (Stage III or IV 
HNC receiving CRT with a curative intent) of this study allowed for a 
high degree of specificity, it further limited generalizability. 
Many of the results found are consistent with the previous literature. 
One area that did not prove to be consistent is regarding the HPV 
status of the tumor, in this study tumors of both positive and negative 
HPV status received PFTs at almost equal rates. Unfortunately, this 
study did not find reduced rates of hospital admissions in patients that 
had a PFT like much of the previous research indicates.4
